Dermatology Doctors in Chesterfield, MO Accepting Medicare

10 Dermatology doctors found. Showing 1 - 10

Dr. George J. Hruza, M.D. Dermatology - Procedural Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1001 Chesterfield Pkwy E, Ste 101, Chesterfield, MO 63017 Phone: 314-878-3839    Fax: 314-878-6575

Wayne Alan Breer, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1001 Chesterfield Pkwy E, Suite 201, Chesterfield, MO 63017 Phone: 636-532-2422    Fax: 636-532-2425

Dr. Mark Charles Kory, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 16216 Baxter Rd, Suite 200, Chesterfield, MO 63017 Phone: 636-532-1000    Fax: 636-532-1605

Regina Cruz Bowers, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 224 S Woods Mill Rd, 570-s, Chesterfield, MO 63017 Phone: 314-878-2556    Fax: 314-275-7442

Dr. Pooja Manjula Swamy Dorward, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1001 Chesterfield Pkwy E, Suite 201, Chesterfield, MO 63017 Phone: 636-532-2422    Fax: 636-532-2425

Daniel Scott Ring, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1001 Chesterfield Pkwy E, Suite 201, Chesterfield, MO 63017 Phone: 636-532-2422    Fax: 636-532-2425

Dr. Susan Akers Blattel, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1001 Chesterfield Pkwy E, Suite 201, Chesterfield, MO 63017 Phone: 636-532-2422    Fax: 636-532-2425

Lawrence E Samuels, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 222 S Woods Mill Rd, 480 North, Chesterfield, MO 63017 Phone: 314-576-7343    Fax: 314-576-7929

Ashley Elizabeth Mcguinness, MD Dermatology Medicare: May Accept Medicare Assignments Practice Location: 1001 Chesterfield Pkwy E Ste 101, Chesterfield, MO 63017 Phone: 314-878-3839

Joseph A Muccini Jr., M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 222 S Woods Mill Rd, 475 North, Chesterfield, MO 63017 Phone: 314-878-0600    Fax: 314-878-0602

News Archive

Genzyme announces 2-year data from eliglustat tartrate Phase 2 trial for Gaucher disease

Genzyme Corporation announced today two-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate (formerly Genz-112638). Continued improvements were observed across all endpoints, including bone disease, at the two-year timepoint, compared with baseline. The two-year results were presented for the first time today at the Lysosomal Disease Network WORLD Symposium in Miami, Fla.

Early antiretroviral treatment for people with HIV/TB coinfection could reduce mortality by half

People with HIV/tuberculosis coinfection who began antiretroviral treatment within six months of starting TB treatment had a 55% lower mortality rate than people with HIV/TB coinfection who did not begin antiretroviral therapy until after they had finished a six-month TB treatment course, according to a study conducted by researchers at the University of KwaZulu-Natal, Business Day reports (Kahn, Business Day, 9/18).

Vitrified eggs as likely to produce on-going pregnancy as fresh eggs

Embryos derived from oocytes (eggs) cryopreserved by the vitrification method are just as likely to produce an on-going pregnancy as those involving fresh oocytes, the 26th annual meeting of the European Society of Human Reproduction and Embryology heard today. Dr. Ana Cobo, Cryobiology Unit director at Institut Universitari - IVI Valencia, Valencia, Spain, told delegates that the results of her team's research would make egg donation both easier and safer in the future.

Research explores links between Alzheimer's and Parkinson′s to COVID-19

In a recent medRxiv* preprint paper, Dr. L. Miguel Martins and colleagues from the University of Cambridge investigate the links between neurodegeneration and COVID-19.

New insights into immune-system changes that may trigger cartilage breakdown

Challenging long-held notions that osteoarthritis is a result mainly of wear and tear on the joints, researchers led by Dr. William H. Robinson of the Department of Veterans Affairs Palo Alto Health Care System and Stanford University have provided new insights into the immune-system changes that may trigger cartilage breakdown.

Read more Medical News

› Verified 6 days ago